---
title: "How Sun Pharma’s US buy could spur other Indian pharma firms' global expansion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284337425.md"
description: "Kunal Dhamesha, Senior Analyst at Macquarie Capital, says Sun Pharma’s U.S. acquisition could encourage its peers to look beyond generics and pursue M&As in specialty and patented medicines, though appetite will vary by company strategy, R&D depth and risk tolerance."
datetime: "2026-04-28T08:01:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284337425.md)
  - [en](https://longbridge.com/en/news/284337425.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284337425.md)
---

# How Sun Pharma’s US buy could spur other Indian pharma firms' global expansion

Kunal Dhamesha, Senior Analyst at Macquarie Capital, says Sun Pharma’s U.S. acquisition could encourage its peers to look beyond generics and pursue M&As in specialty and patented medicines, though appetite will vary by company strategy, R&D depth and risk tolerance.

### Related Stocks

- [SBFM.US](https://longbridge.com/en/quote/SBFM.US.md)
- [SBFMW.US](https://longbridge.com/en/quote/SBFMW.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [MQG.AU](https://longbridge.com/en/quote/MQG.AU.md)

## Related News & Research

- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)
- [Corvus Pharmaceuticals presents Phase 1 soquelitinib data showing durable remissions, favorable safety](https://longbridge.com/en/news/286404245.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)